Replies to post #3568 on GeneSYS ID Inc fka GNID

[DCorleone]

So with all their wisdom, RXSF Players started again, in 2010 under capitalized, with a "new" product in a Niche market, switching roles in Management, and with his mother in laws money (NAPLES TRUST), and under capitalized again.
Will remind you they used PO FINANCING and most of the capital this time, has been spent this time was to pay themselves back through AXIUS, issue compensation shares and packages, and sell shares of RXSF. Minus the $450.00 rent.
Do your DD on PO financing and take a look at Mr. Basile's resume in Media and how he claims his expertise is in restructuring a company like biometrix.
What's even more comical is the 50 cent royalty.


50. We note that Mark Basile resigned as a director of your board on August 2, 2012. Since
he would be considered a related person pursuant to Instruction 1 to Item 404 of
Regulation S-K, please disclose the approximate dollar value of Mr. Basile’s interest in
the July 1, 2010 consulting agreement with Axius Consulting Group. We note that Mr.
Basile was the CEO of Axius Consulting Group as disclosed in Note 3 on page F-9 to the
financial statements.
Executive Compensation, page 45
Summary Compensation Table
51. Please include a footnote disclosing all assumptions made in valuing Ms. Yarde’s stock
award. Refer to Instruction 1 to Items 402(n)(2)(v) and (vi) of Regulation S-K. In
addition, please disclose the material factors that led to Ms. Yarde being awarded
$5,000,000 in stock awards in fiscal year 2012. Refer to Item 402(o)

http://www.sec.gov/Archives/edgar/data/1599385/000000000014011121/filename1.pdf